|
JAZZ | Jazz Pharmaceuticals Plc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.36 |
| Leverage | 65.14% |
| Market Cap | $ 11.0B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -371.0m |
| Margin | -8.95% |
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.